Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Genomic loss of mismatched human leukocyte antigen and leukemia immune escape from haploidentical graft-versus-leukemia.

Vago L, Toffalori C, Ciceri F, Fleischhauer K.

Semin Oncol. 2012 Dec;39(6):707-15. doi: 10.1053/j.seminoncol.2012.09.009. Review.

PMID:
23206847
2.

Clonal evolution including partial loss of human leukocyte antigen genes favoring extramedullary acute myeloid leukemia relapse after matched related allogeneic hematopoietic stem cell transplantation.

Stölzel F, Hackmann K, Kuithan F, Mohr B, Füssel M, Oelschlägel U, Thiede C, Röllig C, Platzbecker U, Schetelig J, Illmer T, Schaich M, Seliger B, Hartmann A, Baretton G, Zietz C, Ehninger G, Schrock E, Bornhäuser M.

Transplantation. 2012 Apr 15;93(7):744-9. doi: 10.1097/TP.0b013e3182481113.

PMID:
22314337
3.

Loss of mismatched HLA in leukemia after stem-cell transplantation.

Vago L, Perna SK, Zanussi M, Mazzi B, Barlassina C, Stanghellini MT, Perrelli NF, Cosentino C, Torri F, Angius A, Forno B, Casucci M, Bernardi M, Peccatori J, Corti C, Bondanza A, Ferrari M, Rossini S, Roncarolo MG, Bordignon C, Bonini C, Ciceri F, Fleischhauer K.

N Engl J Med. 2009 Jul 30;361(5):478-88. doi: 10.1056/NEJMoa0811036.

4.

Mismatched human leukocyte antigen class II-restricted CD8⁺ cytotoxic T cells may mediate selective graft-versus-leukemia effects following allogeneic hematopoietic cell transplantation.

Hirosawa T, Torikai H, Yanagisawa M, Kamei M, Imahashi N, Demachi-Okamura A, Tanimoto M, Shiraishi K, Ito M, Miyamura K, Shibata K, Kikkawa F, Morishima Y, Takahashi T, Emi N, Kuzushima K, Akatsuka Y.

Cancer Sci. 2011 Jul;102(7):1281-6. doi: 10.1111/j.1349-7006.2011.01949.x. Epub 2011 May 9.

5.

Genomic polymorphism and allogeneic hematopoietic transplantation outcome.

Mullighan CG, Petersdorf EW.

Biol Blood Marrow Transplant. 2006 Jan;12(1 Suppl 1):19-27. Review.

6.

Role of alloreactive KIR2DS1(+) NK cells in haploidentical hematopoietic stem cell transplantation.

Marcenaro E, Carlomagno S, Pesce S, Della Chiesa M, Moretta A, Sivori S.

J Leukoc Biol. 2011 Oct;90(4):661-7. doi: 10.1189/jlb.0311137. Epub 2011 Jul 26. Review.

PMID:
21791599
7.

Natural killer cell alloreactivity in allogeneic hematopoietic transplantation.

Ruggeri L, Mancusi A, Burchielli E, Aversa F, Martelli MF, Velardi A.

Curr Opin Oncol. 2007 Mar;19(2):142-7. Review.

PMID:
17272987
8.

Alloreactive natural killer cells in mismatched hematopoietic stem cell transplantation.

Ruggeri L, Capanni M, Mancusi A, Urbani E, Perruccio K, Burchielli E, Tosti A, Topini F, Aversa F, Martelli MF, Velardi A.

Blood Cells Mol Dis. 2004 Nov-Dec;33(3):216-21. Review.

PMID:
15528134
9.

Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity.

Pende D, Marcenaro S, Falco M, Martini S, Bernardo ME, Montagna D, Romeo E, Cognet C, Martinetti M, Maccario R, Mingari MC, Vivier E, Moretta L, Locatelli F, Moretta A.

Blood. 2009 Mar 26;113(13):3119-29. doi: 10.1182/blood-2008-06-164103. Epub 2008 Oct 22.

10.

Different mechanisms causing loss of mismatched human leukocyte antigens in relapsing t(6;11)(q27;q23) acute myeloid leukemia after haploidentical transplantation.

Tamaki H, Fujioka T, Ikegame K, Yoshihara S, Kaida K, Taniguchi K, Kato R, Tokugawa T, Nakata J, Inoue T, Yano A, Eguchi R, Okada M, Maruya E, Saji H, Ogawa H.

Eur J Haematol. 2012 Dec;89(6):497-500. doi: 10.1111/ejh.12017. Epub 2012 Oct 26.

PMID:
23033942
11.

Minor histocompatibility antigens as targets of graft-versus-leukemia reactions.

Falkenburg JH, Marijt WA, Heemskerk MH, Willemze R.

Curr Opin Hematol. 2002 Nov;9(6):497-502. Review.

PMID:
12394171
12.

Graft-versus-leukemia effect of HLA-haploidentical central-memory T-cells expanded with leukemic APCs and modified with a suicide gene.

Casucci M, Perna SK, Falcone L, Camisa B, Magnani Z, Bernardi M, Crotta A, Tresoldi C, Fleischhauer K, Ponzoni M, Gregori S, Caligaris Cappio F, Ciceri F, Bordignon C, Cignetti A, Bondanza A, Bonini C.

Mol Ther. 2013 Feb;21(2):466-75. doi: 10.1038/mt.2012.227. Epub 2012 Nov 13.

13.

Relapse of leukemia with loss of mismatched HLA resulting from uniparental disomy after haploidentical hematopoietic stem cell transplantation.

Villalobos IB, Takahashi Y, Akatsuka Y, Muramatsu H, Nishio N, Hama A, Yagasaki H, Saji H, Kato M, Ogawa S, Kojima S.

Blood. 2010 Apr 15;115(15):3158-61. doi: 10.1182/blood-2009-11-254284. Epub 2010 Feb 1.

14.

At the Bench: Preclinical rationale for exploiting NK cells and γδ T lymphocytes for the treatment of high-risk leukemias.

Norell H, Moretta A, Silva-Santos B, Moretta L.

J Leukoc Biol. 2013 Dec;94(6):1123-39. doi: 10.1189/jlb.0613312. Epub 2013 Oct 9. Review.

15.

Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation.

Huang XJ, Liu DH, Liu KY, Xu LP, Chen H, Han W, Chen YH, Zhang XH, Lu DP.

Biol Blood Marrow Transplant. 2009 Feb;15(2):257-65. doi: 10.1016/j.bbmt.2008.11.025.

16.

Gene Map of the HLA Region, Graves' Disease and Hashimoto Thyroiditis, and Hematopoietic Stem Cell Transplantation.

Sasazuki T, Inoko H, Morishima S, Morishima Y.

Adv Immunol. 2016;129:175-249. doi: 10.1016/bs.ai.2015.08.003. Epub 2015 Dec 1. Review.

PMID:
26791860
17.
19.

Haploidentical hematopoietic stem cell transplantation with a megadose T-cell-depleted graft: harnessing natural and adaptive immunity.

Aversa F, Martelli MF, Velardi A.

Semin Oncol. 2012 Dec;39(6):643-52. doi: 10.1053/j.seminoncol.2012.09.002. Review.

PMID:
23206841

Supplemental Content

Support Center